Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3134]

Study shows that FDA approves cancer drugs faster than EMA

Study shows that FDA approves cancer drugs faster than EMA

EHA 2011: Lack of public research money endangers patients' care - European blood specialists raise the alarm

EHA 2011: Lack of public research money endangers patients' care - European blood specialists raise the alarm

Chemokine CCL2 recruits inflammatory monocytes to facilitate breast tumour metastasis

Chemokine CCL2 recruits inflammatory monocytes to facilitate breast tumour metastasis

OECI quality certificate for five cancer centres in Europe

OECI quality certificate for five cancer centres in Europe

Intermittent versus continuous chemotherapy in advanced colorectal cancer: Results from the COIN trial

Intermittent versus continuous chemotherapy in advanced colorectal cancer: Results from the COIN trial

ASCO 2011: World's leading cancer organisations announce new efforts in response to global cancer crisis

ASCO 2011: World's leading cancer organisations announce new efforts in response to global cancer crisis

Addition of cetuximab to oxaliplatin-based chemotherapy in advanced colorectal cancer: Results from the COIN trial

Addition of cetuximab to oxaliplatin-based chemotherapy in advanced colorectal cancer: Results from the COIN trial

ASCO 2011: Three years of imatinib improves survival for high-risk gastrointestinal stromal tumours

ASCO 2011: Three years of imatinib improves survival for high-risk gastrointestinal stromal tumours

ASCO 2011: Extending pemetrexed treatment as maintenance therapy improves progression-free survival for advanced lung cancer

ASCO 2011: Extending pemetrexed treatment as maintenance therapy improves progression-free survival for advanced...

ASCO 2011: Suggested benefit of bevacizumab for newly diagnosed ovarian cancer patients at high risk of recurrence

ASCO 2011: Suggested benefit of bevacizumab for newly diagnosed ovarian cancer patients at high risk of recurrence

More from ecancer